Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
Jump to:
| Preferred Name | dalteparin | |
| Synonyms |
|
|
| ID |
http://purl.obolibrary.org/obo/dinto_DB06779 |
|
| AHFScode |
20:12.04.16
|
|
| ATCCode |
B01AB04
|
|
| binds |
http://purl.obolibrary.org/obo/dinto_2628 http://purl.obolibrary.org/obo/dinto_2763 http://purl.obolibrary.org/obo/dinto_1967 |
|
| CASRN |
9041-08-1
|
|
| DBBrand |
fragmin eurodal ligoframin boxol low liquemine
|
|
| DBSynonym |
dalteparino natrio druska dalteparina s?dica dalt?parine sodique kabi-2165 dalteparin sodn? s? dalteparinum natricum daltepariininatrium dalteparinnatrium tedelparin sodium dalteparin sodyum heparin fragment kabi 2165 dalteparin-n?trium dalteparyna sodowa
|
|
| Definition |
Dalteparin, a low molecular weight heparin (LMWH) prepared by nitrous acid degradation of unfractionated heparin of porcine intestinal mucosa origin, is an anticoagulant. It is composed of strongly acidic sulphated polysaccharide chains with an average molecular weight of 5000 and about 90% of the material within the range of 2000-9000. LMWHs have a more predictable response, a greater bioavailability, and a longer anti-Xa half life than unfractionated heparin. Dalteparin can also be safely used in most pregnant women. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin.
|
|
| has pharmacological target |
http://purl.obolibrary.org/obo/dinto_2628 |
|
| inhibits |
http://purl.obolibrary.org/obo/dinto_2628 |
|
| is metabolised by | ||
| is substrate of | ||
| label |
dalteparin
|
|
| may interact with | ||
| prefixIRI |
obo2:dinto_DB06779
|
|
| prefLabel |
dalteparin
|
|
| related with | ||
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping